COMPASS Pathways plc (CMPS)
USD 3.93
(-6.43%)
USD 3.93
(-6.43%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 33.04 Million USD | 1614.21% |
| 2022 | 1.92 Million USD | -46.65% |
| 2021 | 3.61 Million USD | 0.0% |
| 2020 | - USD | -100.0% |
| 2019 | 21.08 Million USD | 0.0% |
| 2018 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 32.61 Million USD | -0.58% |
| 2024 Q1 | 32.8 Million USD | -0.73% |
| 2024 Q3 | 32.55 Million USD | -0.2% |
| 2023 Q2 | 32.83 Million USD | 2054.79% |
| 2023 FY | 33.04 Million USD | 1614.21% |
| 2023 Q3 | 32.53 Million USD | -0.93% |
| 2023 Q4 | 33.04 Million USD | 1.59% |
| 2023 Q1 | 1.52 Million USD | -20.95% |
| 2022 Q3 | 2.25 Million USD | -24.47% |
| 2022 FY | 1.92 Million USD | -46.65% |
| 2022 Q2 | 2.98 Million USD | -0.07% |
| 2022 Q1 | 2.98 Million USD | -17.29% |
| 2022 Q4 | 1.92 Million USD | -14.54% |
| 2021 Q1 | - USD | 0.0% |
| 2021 Q3 | - USD | 0.0% |
| 2021 Q4 | 3.61 Million USD | 0.0% |
| 2021 Q2 | - USD | 0.0% |
| 2021 FY | 3.61 Million USD | 0.0% |
| 2020 Q2 | - USD | -100.0% |
| 2020 Q1 | 20.71 Million USD | -1.76% |
| 2020 FY | - USD | -100.0% |
| 2020 Q4 | - USD | 0.0% |
| 2020 Q3 | - USD | 0.0% |
| 2019 FY | 21.08 Million USD | 0.0% |
| 2019 Q4 | 21.08 Million USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.51 Billion USD | 97.812% |
| Addus HomeCare Corporation | 175.18 Million USD | 81.134% |
| AirSculpt Technologies, Inc. | 99.66 Million USD | 66.84% |
| Amedisys, Inc. | 487.21 Million USD | 93.217% |
| American Oncology Network, Inc. | 128.32 Million USD | 74.245% |
| Astrana Health, Inc. | 321.01 Million USD | 89.704% |
| Aveanna Healthcare Holdings Inc. | 1.49 Billion USD | 97.795% |
| IMAC Holdings, Inc. | - USD | -Infinity% |
| biote Corp. | 114.87 Million USD | 71.229% |
| Cryo-Cell International, Inc. | 10.89 Million USD | -203.321% |
| Cross Country Healthcare, Inc. | 5.26 Million USD | -527.492% |
| DocGo Inc. | 46.49 Million USD | 28.92% |
| The Ensign Group, Inc. | 1.87 Billion USD | 98.234% |
| Healthcare Services Group, Inc. | 43.63 Million USD | 24.258% |
| InnovAge Holding Corp. | 113.03 Million USD | 70.761% |
| Assure Holdings Corp. | 14.8 Million USD | -123.235% |
| The Joint Corp. | 16.73 Million USD | -97.492% |
| LifeStance Health Group, Inc. | 511.04 Million USD | 93.533% |
| Mobile-health Network Solutions Class A Ordinary Shares | 657.13 Thousand USD | -4929.423% |
| ModivCare Inc. | 1.14 Billion USD | 97.101% |
| NewGenIvf Group Limited | 332.55 Thousand USD | -9838.265% |
| Novo Integrated Sciences, Inc. | 4.47 Million USD | -639.101% |
| Option Care Health, Inc. | 1.16 Billion USD | 97.167% |
| P3 Health Partners Inc. | 124.64 Million USD | 73.484% |
| P3 Health Partners Inc. | 124.64 Million USD | 73.484% |
| The Pennant Group, Inc. | 329.63 Million USD | 89.974% |
| Surgery Partners, Inc. | 3.06 Billion USD | 98.92% |
| Syra Health Corp. Class A Common Stock | 248.1 Thousand USD | -13221.08% |
| Talkspace, Inc. | - USD | -Infinity% |
| Talkspace, Inc. | - USD | -Infinity% |
| The Oncology Institute, Inc. | 119.81 Million USD | 72.416% |
| The Oncology Institute, Inc. | 119.81 Million USD | 72.416% |